We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Kop - watch the investor presentation from a few days ago. 200k is just what is committed to RTC at the moment
Kop, the split between rtc and molodic test is a 20/80% split and the total capacity is 2m a week hence the 200k figure. ODX has said that they can switch the split dependant on the demand
Gell calm down buddy someone's a little excited this afternoon have a breather have you lost on the share today?
Revenue potential on the day of the first sky interview when it got to 90p:
200k per week RTC POC tests plus 46k per day Elisa antibody tests+ Food + CD4 = circa £88m revenue potential. I'd say potential valuation £250
Revenue potential post placing investment of £11m:
1m per week POC tests mix of RTC antibody and Mologic Anitbody and antigen tests, plus 1m per week Elisa antibody and antigen tests + Food + CD4 = circa £350 revenue potential, potential value circa £900m.
For a 20% dilution they have 400% revenue potential. As an investor i would give up 20% of something 4x bigger any day. If 40p is the price they had to raise at then its not ideal it's discounted, but if its that or miss out on the growth opportunity then it's a no brainer. But it doesn't mean this should be valued at the placing price. If it gets there its not to reflect value it's reflecting market mechanics. This is not a perfect market it's a manipulated market.
The share price says more about he state of our markets than the investment potential of this company.
Merchantbanker - you say 'Omega however post the placing investment will be able to make 2m tests per week' but the RNS today says 200,000 per week at the end of September. That's 10 times less than your figure ...... ???
Rise! Your kidding just making up for the ****ing lost ground df stands for dumb founded thought odx was not on aim
MMS bunts doelts with a c
MB - even more reason to hold. I have just re-read and have missed the doubling of capacity to 100million - can you point me at the right announcement to digest. This is even better than what I had worked through in my mind as I was based at 50million.
People are hung up that RTC is the main stream, it isnt, it is Mologic for me.
Comfortable to sit and see where July takes us.
setting up for a decent rise tomorrow
closing with some strength on the bid which is good to see
At the time of the the 50m related to the UK RTC capability, with ODX at 10m.
Omega however post the placing investment will be able to make 2m tests per week, which is 104m per year. At an average price of £3, that would be £312m of revenue. Plus revenue from the food tolerance and CD4 we are talking £350m revenue potential.
This is HUGE!! And all people can think about is the placing price. Anyone that cant see the value to be unlocked here is blind.
Exactly. Happy to sit smiling and wait until more countries come knocking Minumum broker expectation was 190m this will get there over time and IMHO 300m target isn't over. 15 countries need this test to get back to normality!
No further questions about this, this is the only current solution for mass cheap scalable precise testing!
Chris
I agree - I have taken some more today also. I do not think the interview was brilliant and could have been used a better platform, I am fine saying this and still be a supporter of the company. The interview seems to have consumed the day and this BB has been unbelievable today - no respect or courtesy at all from many.
ODX have capacity to deliver 50million tests per annum (currently)
5 revenue streams from RTC and 4 x Mologic - Mologic only had one previously
Business in China is growing
The write down of £7m tells you that the company see the profit in the tests for Covid in the next 12 - 24 months
If people dont believe in the company then sell and move on and let invested individuals debate the merits cordially.
Been quite an emotional day for most who were waiting for the massive climb on DF that has not materialized - i did expect a bounce, not to 90p but did not expect red - the fundamentals of the company are the same and may take a little longer but still believe this will grow beyond £1. I am not one to believe it is the next Novacyt (that got in at the start and generated revenues from the get go) so anything over £2 is a stretch at the moment but I am invested and will log off the board for the next day or too as it feels like a playground for people to hurl insults, not reasoned conversation over the company. There are some really good posts (PDMS, MB, Elon, Ethio) amongst others and sure a few people are a little bruised today but this is fundamentally a company I still believe in.
Not yet, I also took stock at 45p and 44p which are all swimming against the tide, but this is not my first day on the job and the time to gloat will come.
Been in and out of this and can not believe I just got back in at 43p- I thought I’d missed the boat this morning and it was gonna go to a £1 like everyone else.
Just you wait- this will rise again soon and it’ll be the classic shouldn’t have sold when everyone panicked. When everyone around you loses their head start buying!
Chrishutch - not gloating about your 48p buys now???
Lots to come here and once the churn is cleared we will move up. Am I the only one happy to get more at these levels.